Expression and significance of matrix metallproteinase-25 in gastric carcinoma
Ying Wang, Yanxia Li, Shijie Yu, Weixing Wang, Hesheng Luo
Abstract
Ying Wang, Yanxia Li, Shijie Yu, Weixing Wang, Hesheng Luo
Abstract
Objective To investigate the expression and clinical significance of matrix metallproteinase-25 (MMP-25) in gastric carcinoma.Methods The expression of MMP-25 in 40 cases of normal gastric tissue,40 cases of atrophic gastritis and and 40 cases of gastric carcinoma was detected by using immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR) separately.Results The expression rate of MMP-25 protein in gastric carcinoma and atrophic gastritis was significantly higher than in the normal gastric tissues (95.0% and 82.5% vs.22.5%,P<0.05),and that of MMP-25 mRNA showed the same trend as the former (0.328 ± 0.005 and 0.175 ± 0.002 vs.0.103 ± 0.004,P <0.05).The expression of MMP-25 was significantly correlated with the clinicopathologieal factors such as depth of invasion,lymph node metastasis and tumor sizes (P < 0.05),but not with age,gender,clinical stage and differentiation (P >0.05).Conclusion The MMP-25 is expressed distinctly in gastric carcinoma.MMP-25 may be involved in tumorigenesis and metastasis of gastric carcinoma,and expected to be an important biomarker for gastric carcinoma,which could provide clues for clinical diagnosis of gastric carcinoma. Key words: Matrix metallproteinase-25 ; Gastric carcinoma; Metastasis
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression and clinical significance of matrix metallproteinase-25 (MMP-25) in gastric carcinoma.Methods The expression of MMP-25 in 40 cases of normal gastric tissue,40 cases of atrophic gastritis and and 40 cases of gastric carcinoma was detected by using immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR) separately.Results The expression rate of MMP-25 protein in gastric carcinoma and atrophic gastritis was significantly higher than in the normal gastric tissues (95.0% and 82.5% vs.22.5%,P<0.05),and that of MMP-25 mRNA showed the same trend as the former (0.328 ± 0.005 and 0.175 ± 0.002 vs.0.103 ± 0.004,P <0.05).The expression of MMP-25 was significantly correlated with the clinicopathologieal factors such as depth of invasion,lymph node metastasis and tumor sizes (P < 0.05),but not with age,gender,clinical stage and differentiation (P >0.05).Conclusion The MMP-25 is expressed distinctly in gastric carcinoma.MMP-25 may be involved in tumorigenesis and metastasis of gastric carcinoma,and expected to be an important biomarker for gastric carcinoma,which could provide clues for clinical diagnosis of gastric carcinoma. Key words: Matrix metallproteinase-25 ; Gastric carcinoma; Metastasis
Key concepts: Gastric carcinoma, Atrophic gastritis, Immunohistochemistry, Medicine, Clinical significance, Metastasis, Matrix metalloproteinase, Carcinoma